Could nebivolol be an alternative drug for the treatment of diabetic foot ulcers?
Gulcan
Erim
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001578:Benzopyrans / Q000627:therapeutic use*; D017719:Diabetic Foot / Q000188:drug therapy*; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D000068577:Nebivolol; D009569:Nitric Oxide / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol; D009569:Nitric Oxide